QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vbi-vaccines-was-notified-that-its-common-shares-will-be-delisted-from-nasdaq-effective-as-of-opening-of-business-on-august-8-2024-does-not-intend-to-appeal-the-delisting-determination

On July 30, 2024, the Company received a letter from the listing qualifications department staff of the Nasdaq Stock Market LLC...

 vbi-vaccines-says-on-august-2-2024-the-us-bankruptcy-court-for-the-district-of-delaware-granted-provisional-relief-under-chapter-15-of-the-us-bankruptcy-code-and-scheduled-a-further-hearing-to-consider-the-recognition-of-the-july-30-2024-order

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention a...

 vbi-vaccines-entered-into-a-binding-dip-facility-term-sheet-with-k2-healthventures-pursuant-to-binding-term-sheet-k2hv-has-agreed-to-make-up-to-25m-available-to-co-and-its-units

- Reuters

 vbi-vaccines-shares-resume-trade
VBI Vaccines Shares Resume Trade
07/30/2024 14:15:23

 vbi-vaccines-reports-new-tumor-response-data-from-ongoing-randomized-controlled-phase-2b-study-of-vbi-1901-for-patients-with-recurrent-glioblastoma

Among the 7 patients on VBI-1901 treatment long enough to have 1+ MRI scan at the time of analysis, one partial tumor response ...

 vbi-vaccines-to-present-new-interim-phase-2b-data-from-vbi-1901-in-recurrent-glioblastoma-patients-in-poster-presentation-at-2024-asco-annual-meeting

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention a...

 vbi-vaccines-q1-eps-073-up-from-322-yoy-sales-121m-up-from-48500k-yoy

VBI Vaccines (NASDAQ:VBIV) reported quarterly losses of $(0.73) per share. This is a 77.33 percent increase over losses of $(3....

 why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION